Peripheral Arterial Disease (PAD) Clinical Trial
Official title:
A Randomized, Double-Blind, Multiple-Ascending Dose, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO4905417 Following Intravenous Infusion in Healthy Volunteers and Patients With Peripheral Arterial Disease
This single center, multiple ascending dose study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of RO4905417 at different doses in healthy volunteers and patients with peripheral arterial disease. Three groups of 10 healthy volunteers will receive RO4905417 (either 3mg/kg, 7mg/kg or 20mg/kg) or placebo iv every 28 days for a total of 3 infusions. In addition, two groups of 6 PAD patients will receive RO4905417 (either 3mg/kg, 7mg/kg) or placebo and 1 group of 20 PAD patients will receive 20mg/kg RO4905417 or placebo iv every 28 days for a total of three infusions. The study will have an adaptive design with ongoing assessment of safety and tolerability prior to initiation of the next dose. All subjects will receive 3 doses of RO4905417 or matching placebo at 28 day intervals. The anticipated time on study treatment is 3-12 months, and the target sample size is <100 individuals.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01175850 -
Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease
|
N/A | |
| Active, not recruiting |
NCT00707876 -
Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
|
Phase 2 | |
| Recruiting |
NCT04631848 -
ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease
|
||
| Completed |
NCT00196066 -
Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)
|
Phase 2 | |
| Recruiting |
NCT05834673 -
VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
|
Phase 4 | |
| Recruiting |
NCT05498740 -
Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
|
N/A | |
| Completed |
NCT02780349 -
Evaluation of WIRION™ EPS in Lower Extremities Arteries
|
N/A | |
| Completed |
NCT02254837 -
Zilver PTX Post-Market Study in Japan
|
N/A | |
| Completed |
NCT02254356 -
Zilver Flex Post-Market Study in Japan
|
N/A | |
| Completed |
NCT00689377 -
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention
|
N/A | |
| Active, not recruiting |
NCT05149664 -
A Non-significant Risk Clinical Study: Changes in Perfusion After Therapeutic Ultrasound in Patients With PAD
|
N/A | |
| Recruiting |
NCT04749732 -
Home-based Exercise Therapy for Patients With PAD
|
N/A | |
| Completed |
NCT02936622 -
Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
|
N/A | |
| Completed |
NCT00827619 -
Zilver® Flex™ Vascular Stent Study
|
N/A | |
| Completed |
NCT00862420 -
Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease
|
Phase 3 | |
| Completed |
NCT04753372 -
Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk
|
||
| Recruiting |
NCT05246410 -
A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.
|
N/A | |
| Terminated |
NCT03111238 -
The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
|
Phase 3 | |
| Terminated |
NCT03174522 -
The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
|
Phase 3 |